Business Blog

1 minute reading time (20 words)

GlaxoSmithKline sees sales fall

Drugs giant GlaxoSmithKline (GSK) reports a drop in fourth-quarter sales as demand for its asthma drug Advair remains weak.
×
Stay Informed

When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.

Falling oil price hinders FTSE 100
Strong dollar winners: All-American stocks
 

Comments

Already Registered? Login Here
No comments made yet. Be the first to submit a comment